Zhirong Yang

3.7k total citations · 1 hit paper
104 papers, 2.4k citations indexed

About

Zhirong Yang is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Zhirong Yang has authored 104 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in Zhirong Yang's work include Diabetes Treatment and Management (22 papers), Liver Disease Diagnosis and Treatment (10 papers) and Diabetes Management and Research (9 papers). Zhirong Yang is often cited by papers focused on Diabetes Treatment and Management (22 papers), Liver Disease Diagnosis and Treatment (10 papers) and Diabetes Management and Research (9 papers). Zhirong Yang collaborates with scholars based in China, United Kingdom and United States. Zhirong Yang's co-authors include Siyan Zhan, Feng Sun, Yuan Zhang, Shanshan Wu, Linong Ji, Sanbao Chai, Kai Yu, Lishi Li, Shuxia Guo and Jing Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Zhirong Yang

101 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials

2023 68 citations Zhirong Yang, Di Liu et al. The Lancet Microbe profile →

Peers

Countries citing papers authored by Zhirong Yang

Since Specialization

Citations

This map shows the geographic impact of Zhirong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhirong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhirong Yang more than expected).

Fields of papers citing papers by Zhirong Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhirong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhirong Yang. The network helps show where Zhirong Yang may publish in the future.

Co-authorship network of co-authors of Zhirong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhirong Yang. A scholar is included among the top collaborators of Zhirong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhirong Yang. Zhirong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Application and Quality of Model‐Based Meta‐Analysis in Pharmaceutical Research: A Systematic Cross‐Sectional Analysis and Practical Considerations 2024 ·Clinical Pharmacology & Therapeutics ·Zhirong Yang, (unknown), (unknown), Dongyang Liu, (unknown), Feng Sun	3
2	The optimal threshold of PD-L1 combined positive score to predict the benefit of PD-1 antibody plus chemotherapy for patients with HER2-negative gastric adenocarcinoma: a meta-analysis 2024 ·Cancer Immunology Immunotherapy ·Jibin Li, (unknown), (unknown), Wen‐Long Guan, Yuting Sun, Jing Yang, (unknown), Zhirong Yang, Miao‐Zhen Qiu	7
3	Comparison of GLP‐1 Receptor Agonists, SGLT‐2 Inhibitors, and DPP‐4 Inhibitors as an Add‐On Drug to Insulin Combined With Oral Hypoglycemic Drugs: Umbrella Review 2024 ·Journal of Diabetes Research ·Sanbao Chai, (unknown), (unknown), Shanshan Wu, Zhirong Yang, Feng Sun	3
4	Real-world effectiveness of seasonal influenza vaccination and age as effect modifier: A systematic review, meta-analysis and meta-regression of test-negative design studies 2024 ·Vaccine ·(unknown), Xin Chen, (unknown), (unknown), (unknown), Yiming Tao, Zhike Liu, Zhirong Yang, Siyan Zhan, Feng Sun	24
5	Cognitive protection of incretin‐based therapies in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis based on clinical studies 2023 ·Journal of Diabetes Investigation ·Sanbao Chai, Fengqi Liu, Shuqing Yu, Zhirong Yang, Feng Sun	8
6	Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials breakdown → 2023 ·The Lancet Microbe ·Zhirong Yang, (unknown), (unknown), Di Liu, Teng-Fei Lin, (unknown), (unknown), (unknown), (unknown), (unknown), Fengcai Zhu, Zu‐Yao Yang, (unknown), Zijian Feng, Jin-Ling Tang	68
7	Prevalence of incidental colorectal cancer and polyps in autopsies of different populations: a systematic review with meta-regression analysis 2023 ·European Journal of Epidemiology ·Shuting Wang, Zhirong Yang, Feng Sha, Xingshun Qi, Zhisong He, Chun Ho Szeto, Zu‐Yao Yang, Jin-Ling Tang	4
8	Characteristics and Containment of 74 Imported COVID-19 Outbreaks: Experiences, Lessons, and Implications — China, 2020–2021 2022 ·China CDC Weekly ·(unknown), Wei Chang, (unknown), Teng-Fei Lin, Yi-Wen Jiang, Di Liu, Zhirong Yang, Zu‐Yao Yang, (unknown), Jin-Ling Tang	1
9	Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study 2022 ·BMC Medicine ·Shanshan Wu, Changzheng Yuan, Zhirong Yang, Si Liu, Qian Zhang, Shutian Zhang, Shengtao Zhu	27
10	<p>Statin use and high-dose statin use after ischemic stroke in the UK: a retrospective cohort study</p> 2019 ·Clinical Epidemiology ·Zhirong Yang, Duncan Edwards, Efthalia Massou, Catherine L. Saunders, Carol Brayne, Jonathan Mant	14
11	Effect of incretin-based therapies on cancers of digestive system among 101 595 patients with type 2 diabetes mellitus: a systematic review and network meta-analysis combining 84 trials with a median duration of 30 weeks 2019 ·BMJ Open Diabetes Research & Care ·Sanbao Chai, Shuqing Yu, Zhirong Yang, Shanshan Wu, Le Gao, Haining Wang, Yuan Zhang, Siyan Zhan, Linong Ji, Feng Sun	17
12	The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study 2018 ·Endocrine ·Chengyi Ding, Zhirong Yang, Shengfeng Wang, Feng Sun, Siyan Zhan	34
13	[Risk and related factors on metabolic syndrome among people who had received screening on physical check-up programs, in China]. 2017 ·PubMed ·Hou-Yu Zhao, (unknown), Feng Sun, Xinghua Yang, Zhirong Yang, Shengfeng Wang, Siyan Zhan	1
14	The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials 2017 ·PLoS ONE ·(unknown), Chao Huang, Shanshan Wu, Yang Xu, Ting Cai, Sanbao Chai, Zhirong Yang, Feng Sun, Siyan Zhan	38
15	Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis 2017 ·Clinical Therapeutics ·Shanshan Wu, Sanbao Chai, (unknown), Ting Cai, Yang Xu, Zhirong Yang, Yuan Zhang, Linong Ji, Feng Sun, Siyan Zhan	39
16	[Impact of glucagon-like peptide-1 receptor agonists on nasopharyngitis and upper respiratory tract infection among patients with type 2 diabetes: a network meta-analysis]. 2016 ·PubMed ·(unknown), Shouling Wu, Zhirong Yang, Siyan Zhan, Feng Sun	2
17	Interleukin-4 and interleukin-10 polymorphisms and antituberculosis drug-induced hepatotoxicity in Chinese population 2014 ·Journal of Clinical Pharmacy and Therapeutics ·Jing Wang, (unknown), Shaowen Tang, Xiaozhen Lv, Shihua Wu, Yuan Zhang, Zhirong Yang, Yuqing Xia, D. Chen, Siyan Zhan	7
18	The prevalence of hemophilia in mainland China: a systematic review and meta-analysis. 2014 ·PubMed ·(unknown), (unknown), Zhirong Yang, Huan Yin, Yuanjie Pang, Dong Peng, Siyan Zhan	22
19	Impact of Glp-1RA on Heart Rate, Blood Pressure and Hypertension Among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis 2014 ·Value in Health ·Feng Sun, Sijia Wu, Sanbao Chai, Zhirong Yang, Kai Yu, Siyan Zhan	4
20	Impact of GLP-1 Receptor Agonists on Major Gastrointestinal Disorders for Type 2 Diabetes Mellitus: A Mixed Treatment Comparison Meta-Analysis 2012 ·Experimental Diabetes Research ·Feng Sun, Kai Yu, Zhirong Yang, Shanshan Wu, Yuan Zhang, Luwen Shi, Linong Ji, Siyan Zhan	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact